ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Mycobacterial periprosthetic joint infection of the hip and knee: current concepts in diagnosis and management.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMycobacterial periprosthetic joint infection (PJI) of the hip and knee is rare and difficult to diagnose and treat. This narrative review summarizes current evidence on the epidemiology, microbiology, diagnosis, surgical management, antimicrobial therapy, and outcomes of PJI caused by Mycobacterium tuberculosis complex (MTB) and nontuberculous mycobacteria (NTM).
methodsWe synthesized evidence from clinical studies, systematic reviews, consensus documents, and relevant case series addressing hip and knee mycobacterial PJI. Evidence on epidemiology, diagnostic methods, surgical strategies, antimicrobial regimens, and outcomes was reviewed to derive practical clinical considerations.
resultsMycobacterial PJI should be suspected in culture-negative or indolent infection, failure of conventional antibacterial therapy, immunosuppression, or relevant tuberculosis exposure. Diagnosis requires appropriate specimens for prolonged mycobacterial culture, histopathology, molecular testing when available, and antimicrobial susceptibility testing. Management should integrate surgery with prolonged, species-directed multidrug therapy. Two-stage revision is the most frequently reported reconstructive strategy when reimplantation is feasible, but comparative evidence does not establish a universally superior operation. Debridement with implant retention may be considered only in carefully selected early infections, including selected rapidly growing mycobacterial infections. Regimens and treatment duration differ substantially between MTB and NTM.
conclusionEarly recognition and accurate microbiological diagnosis are essential. Management requires multidisciplinary collaboration and individualized medical-surgical treatment. Because current recommendations derive mainly from retrospective studies and case series, multicenter studies using standardized diagnostic, therapeutic, functional, and outcome definitions are needed.
Indexed as
Identifiers
42627466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.